Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas
Shanghai Pharma Biotherapeutics USA Inc.
Shanghai Pharma Biotherapeutics USA Inc.
Rain Oncology Inc
Pfizer
Fred Hutchinson Cancer Center
Institut Bergonié
Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
University of South Florida
City of Hope Medical Center